Back
ESC Professional Premium Access

Outcomes of heart failure with preserved ejection fraction (HFpEF) in patients with and without cardiac amyloidosis: analysis from 2016-2019 national inpatient sample

Session: A focus on cardiac amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor S. Kambalapalli (Flint, US)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Soumya Kambalapalli

McLaren Flint Hospital, Flint (United States of America)
0 follower

7 more presentations in this session

Myocardial ischaemia in cardiac amyloidosis: a change of perspective

Speaker: Doctor A. Ioannou (Greater London, GB)

Access
Abstract
Slides
Like
Thumbnail

Coronary flow reserve by PET 13N-ammonia in patients with hereditary transthyretin amyloidosis with and without cardiac involvement.

Speaker: Doctor A. Comte de Alencar Neto (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Sustained vasodilation after cold pressor test is an independent predictor of poor survival in primary AL amyloidosis.

Speaker: Doctor E. Maneta (Salt Lake City, US)

Access
Abstract
Slides
Like
Thumbnail

Incidence and risk factors for pacemaker implantation in light chain and transthyretin cardiac amyloidosis

Speaker: Doctor A. Porcari (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Prognostic implications of clinical phenotype and severity of cardiac involvement in patients presenting with immunoglobulin light chain amyloidosis

Speaker: Doctor A. Porcari (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

A focus on cardiac amyloidosis

Speakers: Doctor S. Kambalapalli, Doctor A. Ioannou, Doctor A. Comte de Alencar Neto, Doctor E. Maneta, Doctor A. Porcari...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources